Cipla Ltd. (CIPLA)
BSE
Closed
Aug 26, 2026
Day's Range
1,400.4052 wk Range
1,165.55Overview - CIPLA - Cipla Ltd.
Key Statistics
Valuation
Enterprise Value
976.22B
P/E (Trailing)
‪25.39‬
P/E (Forward)
‪25.19‬
PEG Ratio
‪25.19‬
Price / Sales (TTM)
‪4.12‬
Price / Book
‪3.50‬
EV / EBITDA
‪15.32‬
Profitability
Gross Margin
‪62.31%‬
Profit Margin
‪16.25%‬
Operating Margin
‪14.02%‬
Ownership
Shares Outstanding
807.78M
Float
563.37M
Held by Insiders
‪30.78%‬
Held by Institutions
‪40.33%‬
Price stats
Beta
‪-0.05‬
50-Day Avg
‪1,456.22‬
200-Day Avg
‪1,507.22‬
Dividends
Payout Ratio
‪23.11%‬
Frequency
Annual
Analyst Consensus
36 analysts
Average price target
‪₹ 1,458.53‬Market Cap - CIPLA - Cipla Ltd.
Peers - CIPLA - Cipla Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
Profile Summary - CIPLA - Cipla Ltd.
About
Cipla Ltd. is an Indian pharmaceutical company that develops, manufactures, and markets a broad range of medicines and healthcare products for patients and healthcare providers worldwide. Its current business centers on pharmaceuticals and new ventures, with a portfolio that includes generic medicines, active…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
